PANews reported on September 29 that Faraday Future founder Jia Yueting wrote that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market value. This strategic investment is expected to be completed this week, and the encryption flywheel is accelerating.

Earlier on September 20, it was reported that Faraday Future plans to invest US$41 million in Qualigen through PIPE for cryptocurrency business ; Qualigen will be renamed CXC10 and transformed into an encryption and Web3 business platform.